About this Study
Condition
Intervention
Phase
Human Immunodeficiency Virus
Drug: MK-0518
Phase III
ENROLLMENT IN THIS STUDY IS CLOSED.
BENCHMRK
You may be eligible for the study if you:
Are HIV positive with viral load greater than 5,000.
Have never taken medication to treat your HIV.
Are 18 years of age or older.
Participation in this study includes at no cost:
Study-related doctor visits
Investigational study drug
Laboratory testing
In many cases, reimbursement for transportation and childcare will be available.
Copyright © 2005-2007 Merck & Co., Inc., All rights reserved.
